138 related articles for article (PubMed ID: 27096720)
1. Ketamine Metabolites Enantioselectively Decrease Intracellular D-Serine Concentrations in PC-12 Cells.
Singh NS; Rutkowska E; Plazinska A; Khadeer M; Moaddel R; Jozwiak K; Bernier M; Wainer IW
PLoS One; 2016; 11(4):e0149499. PubMed ID: 27096720
[TBL] [Abstract][Full Text] [Related]
2. Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors.
Moaddel R; Abdrakhmanova G; Kozak J; Jozwiak K; Toll L; Jimenez L; Rosenberg A; Tran T; Xiao Y; Zarate CA; Wainer IW
Eur J Pharmacol; 2013 Jan; 698(1-3):228-34. PubMed ID: 23183107
[TBL] [Abstract][Full Text] [Related]
3. (R,S)-Ketamine metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine increase the mammalian target of rapamycin function.
Paul RK; Singh NS; Khadeer M; Moaddel R; Sanghvi M; Green CE; O'Loughlin K; Torjman MC; Bernier M; Wainer IW
Anesthesiology; 2014 Jul; 121(1):149-59. PubMed ID: 24936922
[TBL] [Abstract][Full Text] [Related]
4. Stereochemical and structural effects of (2R,6R)-hydroxynorketamine on the mitochondrial metabolome in PC-12 cells.
Faccio AT; Ruperez FJ; Singh NS; Angulo S; Tavares MFM; Bernier M; Barbas C; Wainer IW
Biochim Biophys Acta Gen Subj; 2018 Jun; 1862(6):1505-1515. PubMed ID: 29526507
[TBL] [Abstract][Full Text] [Related]
5. Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine.
Chen BK; Luna VM; LaGamma CT; Xu X; Deng SX; Suckow RF; Cooper TB; Shah A; Brachman RA; Mendez-David I; David DJ; Gardier AM; Landry DW; Denny CA
Neuropsychopharmacology; 2020 Aug; 45(9):1545-1556. PubMed ID: 32417852
[TBL] [Abstract][Full Text] [Related]
6. The distribution and clearance of (2S,6S)-hydroxynorketamine, an active ketamine metabolite, in Wistar rats.
Moaddel R; Sanghvi M; Dossou KS; Ramamoorthy A; Green C; Bupp J; Swezey R; O'Loughlin K; Wainer IW
Pharmacol Res Perspect; 2015 Aug; 3(4):e00157. PubMed ID: 26171236
[TBL] [Abstract][Full Text] [Related]
7. Subchronic administration of (R,S)-ketamine induces ketamine ring hydroxylation in Wistar rats.
Moaddel R; Sanghvi M; Ramamoorthy A; Jozwiak K; Singh N; Green C; O'Loughlin K; Torjman M; Wainer IW
J Pharm Biomed Anal; 2016 Aug; 127():3-8. PubMed ID: 27017097
[TBL] [Abstract][Full Text] [Related]
8. (2
Kang H; Park P; Han M; Tidball P; Georgiou J; Bortolotto ZA; Lodge D; Kaang BK; Collingridge GL
Brain Neurosci Adv; 2020; 4():2398212820957847. PubMed ID: 33088919
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine.
Shaffer CL; Dutra JK; Tseng WC; Weber ML; Bogart LJ; Hales K; Pang J; Volfson D; Am Ende CW; Green ME; Buhl DL
Neuropharmacology; 2019 Jul; 153():73-81. PubMed ID: 31015046
[TBL] [Abstract][Full Text] [Related]
10. Functional and immunocytochemical characterization of D-serine transporters in cortical neuron and astrocyte cultures.
Shao Z; Kamboj A; Anderson CM
J Neurosci Res; 2009 Aug; 87(11):2520-30. PubMed ID: 19382234
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression.
Zhao X; Venkata SL; Moaddel R; Luckenbaugh DA; Brutsche NE; Ibrahim L; Zarate CA; Mager DE; Wainer IW
Br J Clin Pharmacol; 2012 Aug; 74(2):304-14. PubMed ID: 22295895
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic Modeling of Ketamine Enantiomers and Their Metabolites After Administration of Prolonged-Release Ketamine With Emphasis on 2,6-Hydroxynorketamines.
Weiss M; Siegmund W
Clin Pharmacol Drug Dev; 2022 Feb; 11(2):194-206. PubMed ID: 34265182
[TBL] [Abstract][Full Text] [Related]
13. Ketamine Metabolite (2
Joseph TT; Bu W; Lin W; Zoubak L; Yeliseev A; Liu R; Eckenhoff RG; Brannigan G
ACS Chem Neurosci; 2021 May; 12(9):1487-1497. PubMed ID: 33905229
[TBL] [Abstract][Full Text] [Related]
14. D-serine uptake and release in PC-12 cells measured by chiral microchip electrophoresis-mass spectrometry.
Li X; McCullum C; Zhao S; Hu H; Liu YM
ACS Chem Neurosci; 2015 Apr; 6(4):582-7. PubMed ID: 25611520
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor.
Sałat K; Siwek A; Starowicz G; Librowski T; Nowak G; Drabik U; Gajdosz R; Popik P
Neuropharmacology; 2015 Dec; 99():301-7. PubMed ID: 26240948
[TBL] [Abstract][Full Text] [Related]
16. A novel Na(+) -Independent alanine-serine-cysteine transporter 1 inhibitor inhibits both influx and efflux of D-Serine.
Sakimura K; Nakao K; Yoshikawa M; Suzuki M; Kimura H
J Neurosci Res; 2016 Oct; 94(10):888-95. PubMed ID: 27302861
[TBL] [Abstract][Full Text] [Related]
17. P2X7 R-mediated Ca(2+) -independent d-serine release via pannexin-1 of the P2X7 R-pannexin-1 complex in astrocytes.
Pan HC; Chou YC; Sun SH
Glia; 2015 May; 63(5):877-93. PubMed ID: 25630251
[TBL] [Abstract][Full Text] [Related]
18. The effect of L-theanine and S-ketamine on d-serine cellular uptake.
Lakatos PP; Vincze I; Nyariki N; Bagaméry F; Tábi T; Szökő É
Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140473. PubMed ID: 32574765
[TBL] [Abstract][Full Text] [Related]
19. Enantioselective inhibition of d-serine transport by (S)-ketamine.
Singh NS; Bernier M; Camandola S; Khadeer MA; Moaddel R; Mattson MP; Wainer IW
Br J Pharmacol; 2015 Sep; 172(18):4546-4559. PubMed ID: 26140427
[TBL] [Abstract][Full Text] [Related]
20. In vivo D-serine hetero-exchange through alanine-serine-cysteine (ASC) transporters detected by microelectrode biosensors.
Maucler C; Pernot P; Vasylieva N; Pollegioni L; Marinesco S
ACS Chem Neurosci; 2013 May; 4(5):772-81. PubMed ID: 23581544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
